Quality control is pervasive in most modern business, but, surprisingly, is in its infancy in medicine in general-and cardiovascular imaging in particular. The increasing awareness of the cost of cardiovascular imaging, matched by a desire to show benefits from imaging to patient outcome, suggests that this deficiency should be reassessed. Demonstration of improved quality has been proposed to require a focus on several domains: laboratory organization, patient selection, image acquisition, image interpretation, and results communication. Improvement in these steps will require adoption of a variety of interventions, including laboratory accreditation, appropriate use criteria, and continuous quality control and enhancements in reporting, but the evidence base for the benefit of interventions on these steps has been sparse. The purpose of this review is to evaluate the current status and future goals of developing the evidence base for these processes in cardiovascular imaging. (J Am Coll Cardiol Img 2016;9:294-305)
T he initial adoption of scientific methods of quality control (QC) from industry to medicine started >50 years ago (1) . Despite sporadic interest in QC, several markers point toward ongoing limitations of health care QC, including inappropriate care (2) , disagreements among experts (3), geographic and provider variations in practice and care (4) , and medical injuries to patients (5) . Fortunately, the possibility of harm is limited in imaging (although there are potential risks from stress testing, contrast agents, radiation exposure, or misinterpretation of tests), but the other markers are prevalent in imaging practice.
A series of influential frameworks have sought to address these concerns and to encourage evidencebased medicine (6) . Outside of the assessment of process measures, the efficacy of current strategies to improve care remains a subject of ongoing research.
The field poses a number of challenges, not the least of which is that the role of the randomized controlled trial-the conventional approach to studying causal relationships and incremental benefit/harm-has limitations in the evaluation of complex social and interpersonal systems that characterize the interaction of imaging services with clinical practice.
The growth of cardiovascular imaging has had a sizable economic impact, but the contribution of imaging to changes in disease outcomes is unclear.
Defining the contribution of existing and new tests to patient outcome and building an effective cardiovascular imaging QC process is an important goal (7) . This paper reviews the components of imaging of this review is to facilitate the wider adoption of the QC process.
QUALITY CONTROL
The ultimate goal of imaging is to provide a single, appropriate test at the right time and to the right patient that is performed, interpreted, and integrated correctly into patient management (Central Illustration) (7) . The following sections seek to define the evidence base for the 4 defined domains that affect patient outcomes (7) assuring that the laboratory meets minimum requirements and has a QC model in place. IAC stipulates that laboratories should have medical directors preferably with level 3 training (or equivalent), technical directors and technical staff with appropriate credentials, and interpreters at level 2 training or higher (8) (9) (10) (11) . However, the variation in stipulated training levels between jurisdictions ( involved in research and training should be at the "advanced standards" level (15) .
Although many of these suggestions are logical, this process would be strengthened if evidence could be gathered to support the impact of these laboratory measures on patient outcome. This is particularly the case in relation to the application (and more importantly mandating) of this process in smaller laboratories and cardiology practices.
PATIENT SELECTION. The initial step to improve patient selection has been the development of appropriate use criteria (AUC). The growth of cardiovascular imaging has been an important catalyst to the development of these guidelines, and although their uptake has been slow outside of North America, this problem is not limited to just that jurisdiction.
Thus, although the presence of different workflows may inhibit the implementation of exactly the same model, it seems likely that similar guidance will be needed in other regions of the world. (21) . There are also limited data to support the effect of AUC-based educational interventions on the echocardiography-ordering behavior of physicians.
To our knowledge, only 1 paper has shown the number of ordered inpatient TTE and inappropriate TTE per day in an academic hospital were significantly reduced during an educational intervention to interns in training (30) , and in this, the effect of intervention was not sustained (31) . The evidence that AUC is able to reduce numbers of requested TTE is limited (32) . Unfortunately, the coding of AUC has limited reproducibility and this subjectivity makes it susceptible to bias (21) . A partial solution to this at a local level might be for the QC leader to code the
CENTRAL ILLUSTRATION Quality Control in Practice
The potential benefits of imaging may be compromised by quality problems at a number of points between between patient problem and patient outcome. Inappropriate patient selection, problems with image acquisition and interpretation, poor results communication, and inappropriate clinical decisions may all compromise the ability to add value from imaging. These potential problems may be assessed by quality control measures in the laboratory and the clinical interface.
Eskandari et al.
Quality Control in CV Imaging Reports in imaging laboratories should be uniform and include key elements, with a common terminology used across all modalities and comparison with previous studies (19, 44) . One aspect that has received scant attention is the avoidance of over-reporting of extraneous material (e.g., minutiae of diastolic function assessment), which may be confusing to the nonspecialist.
Structured reporting, using a menu of drop-down statements to generate a report improves the consistency of interpreter comments and digitally stored data (45) . Although this type of facilitated reporting is thought to avoid discrepancies in report transcription, a single-center study showed contradictory statements to be present in the final TTE report in 4.0% of TTE, 3.6% of TEE, and 7.1% of stress 
REPORTED EXPERIENCE WITH QC
As discussed previously, the lack of evidence supporting quality assessment from administrative data has left empirical evaluation of accuracy and reproducibility at a laboratory level as the main tools for QC. The existing published data-mainly in echocardiography-suggests that both variability and accuracy can be improved by formative review process.
EF. The assessment of global LV function is among the most common reasons for the performance of echocardiography. However, with test-retest variability as high as 14% (50), it is apparent that inconsistent measurements could alter the decisions for device therapy, or medical therapy for heart failure. Eskandari et al.
Quality Control in CV Imaging There appears to be a need for a simplified hierarchy in diastolic function interpretation (53) .
VALVULAR HEART DISEASE. In valvular heart disease, poor QC can lead to discordant advice from one visit to the next or between similar patients.
Unfortunately, the problem of variability cannot be solely addressed by quantitation because technical Misclassification rate of visually estimated EF compared with expert-derived quantified EF before (green bars) and after intervention (pink bars) in 3 groups of all cases, mid-range EF (30% to 55%), and outside mid-range EF (<30% and >55%). Misclassification for all cases was reduced significantly after educational intervention. EF ¼ ejection fraction. 
SAFETY
The downside of echocardiography is more in the realm of diagnostic limitation/misinterpretation than medical harm. Poor image quality can be significantly improved with the use of ultrasound contrast agents.
Anaphylactic shock has been a rarely reported severe 
CONCLUSIONS
There is a historical "lack of awareness" about the merits of QC in cardiac imaging. A systematic approach with defined domains and actions to confront the problem has been proposed by relevant organizations, but the uptake of the QC process has been patchy. Quite simple steps can be of value (Table 4) , and ongoing efforts are needed to improve QC programs and develop an optimal model for widespread implementation. Such a process will be an important step in linking imaging quality to patient outcomes. Quality Control in CV Imaging
